Literature DB >> 25398757

Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Adam J Filgo1, Erin M Quist2, Mark J Hoenerhoff3, Amy E Brix4, Grace E Kissling5, Suzanne E Fenton6.   

Abstract

Perfluorooctanoic acid (PFOA) is a ubiquitous pollutant that causes liver toxicity in rodents, a process believed to be dependent on peroxisome proliferator-activated receptor-alpha (PPARα) activation. Differences between humans and rodents have made the human relevance of some health effects caused by PFOA controversial. We analyzed liver toxicity at 18 months following gestational PFOA exposure in CD-1 and 129/Sv strains of mice and compared PFOA-induced effects between strains and in wild type (WT) and PPARα-knockout (KO) 129/Sv mice. Pregnant mice were exposed daily to doses (0.01-5 mg/kg/BW) of PFOA from gestation days 1 to 17. The female offspring were necropsied at 18 months, and liver sections underwent a full pathology review. Hepatocellular adenomas formed in PFOA-exposed PPARα-KO 129/Sv and CD-1 mice and were absent in untreated controls from those groups and WT 129/Sv. Hepatocellular hypertrophy was significantly increased by PFOA exposure in CD-1, and an increased severity was found in WT 129/Sv mice. PFOA significantly increased nonneoplastic liver lesions in PPARα-KO mice (hepatocyte hypertrophy, bile duct hyperplasia, and hematopoietic cell proliferation). Low-dose gestational exposures to PFOA induced latent PPARα-independent liver toxicity that was observed in aged mice. Evidence of liver toxicity in PPARα-KO mice warrants further investigation into PPARα-independent pathways.
© 2014 by The Author(s).

Entities:  

Keywords:  PFOA; PPARα; developmental exposure; liver; pathology; tumor

Mesh:

Substances:

Year:  2014        PMID: 25398757      PMCID: PMC4431958          DOI: 10.1177/0192623314558463

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  30 in total

1.  Perfluoroalkyl acids: recent research highlights.

Authors:  Christopher Lau
Journal:  Reprod Toxicol       Date:  2012-03-09       Impact factor: 3.143

2.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.

Authors:  Christopher Lau; Julie R Thibodeaux; Roger G Hanson; Michael G Narotsky; John M Rogers; Andrew B Lindstrom; Mark J Strynar
Journal:  Toxicol Sci       Date:  2006-01-16       Impact factor: 4.849

3.  Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.

Authors:  Margy L Takacs; Barbara D Abbott
Journal:  Toxicol Sci       Date:  2006-10-17       Impact factor: 4.849

Review 4.  Mode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance.

Authors:  James E Klaunig; Barbara A Hocevar; Lisa M Kamendulis
Journal:  Reprod Toxicol       Date:  2011-11-22       Impact factor: 3.143

5.  Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice.

Authors:  Yong Zhao; Ying S Tan; Mark J Strynar; Gloria Perez; Sandra Z Haslam; Chengfeng Yang
Journal:  Reprod Toxicol       Date:  2012-03-05       Impact factor: 3.143

6.  Peroxisome proliferator activated receptor-alpha expression in human liver.

Authors:  C N Palmer; M H Hsu; K J Griffin; J L Raucy; E F Johnson
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

7.  Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring.

Authors:  Sally S White; Antonia M Calafat; Zsuzsanna Kuklenyik; LaTonya Villanueva; Robert D Zehr; Laurence Helfant; Mark J Strynar; Andrew B Lindstrom; Julie R Thibodeaux; Carmen Wood; Suzanne E Fenton
Journal:  Toxicol Sci       Date:  2006-11-28       Impact factor: 4.849

8.  Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures.

Authors:  Cynthia J Wolf; Suzanne E Fenton; Judith E Schmid; Antonia M Calafat; Zsuzsanna Kuklenyik; Xavier A Bryant; Julie Thibodeaux; Kaberi P Das; Sally S White; Christopher S Lau; Barbara D Abbott
Journal:  Toxicol Sci       Date:  2006-11-10       Impact factor: 4.849

9.  Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.

Authors:  Thomas Hays; Ivan Rusyn; Amanda M Burns; Mary J Kennett; Jerrold M Ward; Frank J Gonzalez; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2004-09-24       Impact factor: 4.944

10.  Polyfluoroalkyl chemicals in the serum and milk of breastfeeding women.

Authors:  Ondine S von Ehrenstein; Suzanne E Fenton; Kayoko Kato; Zsuzsanna Kuklenyik; Antonia M Calafat; Erin P Hines
Journal:  Reprod Toxicol       Date:  2009-03-06       Impact factor: 3.143

View more
  19 in total

1.  Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups.

Authors:  Weihsueh A Chiu; Kathryn Z Guyton; Matthew T Martin; David M Reif; Ivan Rusyn
Journal:  ALTEX       Date:  2017-07-24       Impact factor: 6.043

2.  Hepatic Mitochondrial Alteration in CD-1 Mice Associated with Prenatal Exposures to Low Doses of Perfluorooctanoic Acid (PFOA).

Authors:  Erin M Quist; Adam J Filgo; Connie A Cummings; Grace E Kissling; Mark J Hoenerhoff; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2014-10-16       Impact factor: 1.902

3.  The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.

Authors:  Emily S Marques; Juliana Agudelo; Emily M Kaye; Seyed Mohamad Sadegh Modaresi; Marisa Pfohl; Jitka Bečanová; Wei Wei; Marianne Polunas; Michael Goedken; Angela L Slitt
Journal:  Toxicology       Date:  2021-08-28       Impact factor: 4.571

Review 4.  Placenta Disrupted: Endocrine Disrupting Chemicals and Pregnancy.

Authors:  Jeremy Gingrich; Elvis Ticiani; Almudena Veiga-Lopez
Journal:  Trends Endocrinol Metab       Date:  2020-04-02       Impact factor: 12.015

5.  Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin.

Authors:  Deanna M Salter; Wei Wei; Pragati P Nahar; Emily Marques; Angela L Slitt
Journal:  Toxicol Sci       Date:  2021-07-16       Impact factor: 4.849

6.  Per- and polyfluoroalkyl mixtures toxicity assessment "Proof-of-Concept" illustration for the hazard index approach.

Authors:  M M Mumtaz; M C Buser; H R Pohl
Journal:  J Toxicol Environ Health A       Date:  2021-03-23

7.  Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes.

Authors:  Emily Marques; Marisa Pfohl; Wei Wei; Giuseppe Tarantola; Lucie Ford; Ogochukwu Amaeze; Jessica Alesio; Sangwoo Ryu; Xuelian Jia; Hao Zhu; Geoffrey D Bothun; Angela Slitt
Journal:  Toxicol Appl Pharmacol       Date:  2022-03-23       Impact factor: 4.460

Review 8.  Mediating Roles of PPARs in the Effects of Environmental Chemicals on Sex Steroids.

Authors:  Qiansheng Huang; Qionghua Chen
Journal:  PPAR Res       Date:  2017-07-27       Impact factor: 4.964

Review 9.  Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.

Authors:  Suzanne E Fenton; Alan Ducatman; Alan Boobis; Jamie C DeWitt; Christopher Lau; Carla Ng; James S Smith; Stephen M Roberts
Journal:  Environ Toxicol Chem       Date:  2020-12-07       Impact factor: 4.218

10.  Dialysis Membranes Influence Perfluorochemical Concentrations and Liver Function in Patients on Hemodialysis.

Authors:  Wen-Sheng Liu; Hsiang Lin Chan; Yen-Ting Lai; Chih-Ching Lin; Szu-Yuan Li; Chih-Kuang Liu; Han-Hsing Tsou; Tsung-Yun Liu
Journal:  Int J Environ Res Public Health       Date:  2018-11-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.